Sarepta Therapeutics Inc (SRPT)
124.25
+7.19
(+6.14%)
USD |
NASDAQ |
Apr 24, 16:00
124.25
0.00 (0.00%)
After-Hours: 19:24
Sarepta Therapeutics Price: 124.25 for April 24, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 23, 2024 | 117.50 | 119.91 | 117.06 | 117.06 | 385438.0 |
Apr 22, 2024 | 116.63 | 118.43 | 114.48 | 116.96 | 889164.0 |
Apr 19, 2024 | 116.55 | 117.74 | 114.37 | 115.62 | 641236.0 |
Apr 18, 2024 | 117.55 | 118.90 | 115.79 | 116.55 | 498572.0 |
Apr 17, 2024 | 117.00 | 119.08 | 115.93 | 117.89 | 546229.0 |
Apr 16, 2024 | 117.60 | 118.69 | 116.94 | 117.29 | 592917.0 |
Apr 15, 2024 | 122.18 | 122.98 | 117.78 | 118.31 | 860486.0 |
Apr 12, 2024 | 124.17 | 124.82 | 121.49 | 122.87 | 656117.0 |
Apr 11, 2024 | 127.28 | 127.49 | 123.40 | 124.45 | 618223.0 |
Apr 10, 2024 | 124.13 | 126.47 | 123.87 | 126.31 | 523340.0 |
Apr 09, 2024 | 126.46 | 127.41 | 126.07 | 126.98 | 286092.0 |
Apr 08, 2024 | 126.17 | 126.68 | 124.37 | 126.39 | 559199.0 |
Apr 05, 2024 | 125.43 | 127.64 | 123.85 | 126.08 | 303511.0 |
Apr 04, 2024 | 127.22 | 128.23 | 124.87 | 125.79 | 747118.0 |
Apr 03, 2024 | 126.07 | 128.60 | 125.17 | 126.92 | 851048.0 |
Apr 02, 2024 | 127.68 | 128.80 | 125.80 | 127.00 | 519194.0 |
Apr 01, 2024 | 129.38 | 129.38 | 126.11 | 128.40 | 858391.0 |
Mar 28, 2024 | 131.16 | 131.16 | 127.83 | 129.46 | 811626.0 |
Mar 27, 2024 | 129.25 | 130.32 | 127.36 | 130.23 | 592604.0 |
Mar 26, 2024 | 129.83 | 129.97 | 128.00 | 128.25 | 530108.0 |
Mar 25, 2024 | 127.00 | 128.95 | 126.00 | 127.94 | 396054.0 |
Mar 22, 2024 | 125.14 | 128.19 | 124.74 | 127.54 | 628292.0 |
Mar 21, 2024 | 126.98 | 128.44 | 124.27 | 124.94 | 458091.0 |
Mar 20, 2024 | 124.37 | 126.11 | 122.72 | 126.08 | 551513.0 |
Mar 19, 2024 | 123.80 | 125.60 | 122.65 | 124.06 | 811173.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
62.69
Minimum
Jun 16 2022
178.74
Maximum
Dec 22 2020
109.01
Average
111.47
Median
Aug 08 2022
Price Benchmarks
PTC Therapeutics Inc | 25.22 |
Vertex Pharmaceuticals Inc | 400.73 |
Regenxbio Inc | 16.05 |
CytomX Therapeutics Inc | 1.64 |
Apellis Pharmaceuticals Inc | 49.86 |
Price Related Metrics
PS Ratio | 9.233 |
Price to Book Value | 13.57 |
Earnings Yield | -4.69% |
Market Cap | 11.66B |